Clinical trial evidence from SURMOUNT-1 The landmark SURMOUNT-1 trial, published by Jastreboff and colleagues, provided some of the cleanest data on tirzepatide and hair loss
Plan your vial supply accordingly to avoid running short during the maintenance phase
So far, Tahiri said, the major LLMs appear to be surfacing information from a broad range of companies, which is giving a great opportunity to small and medium enterprises who are doing a good job in understanding the consumer and providing products that are adapted. Thats another reason to invest in research and development, she said, adding, R&D is the new marketing. Companies that focus on real science, real work [and] depth in how you really understand the consumer from an R&D perspective stand to benefit, Tahiri said
Research Dosing Protocols Based on clinical trial data, most researchers follow a gradual titration protocol: TYPICAL ESCALATION SCHEDULE: Weeks 1-4: 2mg weekly Weeks 5-8: 4mg weekly Weeks 9-12: 8mg weekly Week 13+: 12mg weekly (maintenance dose) This gradual increase helps minimize side effects while allowing the body to adjust to the compound